SCHEMBL7445463

SCHEMBL7445463

Cc1nc(S(=O)(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2ccc(OCCCN(C)C)cc2)C(=O)O)c[nH]1

nearest known ligand 0.48

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
ITGB1 P05556 13/20 0.48
ITGA4 P13612 5/20 0.48
ITGB7 P26010 2/20 0.48
ITGA5 P08648 4/20 0.46
ITGAV P06756 7/20 0.43
ITGA2 P17301 1/20 0.40
ITGB3 P05106 5/20 0.40
ITGA2B P08514 4/20 0.40
MMP13 P45452 1/20 0.38
ADAM17 P78536 1/20 0.38
UTS2R Q9UKP6 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4413756 0.87 ITGB1 (0.53) ITGB1ITGA4ITGB7ITGA5ITGAV
SCHEMBL7448555 0.86 ITGB1 (0.47) ITGB1ITGA4ITGB7ITGA5ITGAV
SCHEMBL6429310 0.86 ITGB1 (0.51) ITGB1ITGA4ITGB7ITGA5ITGAV
SCHEMBL7325939 0.85 ITGB1 (0.48) ITGB1ITGA4ITGB7ITGA5ITGAV
SCHEMBL7315770 0.85 ITGA4 (0.59) ITGB1ITGA4ITGB7ITGA5ITGAV
SCHEMBL7073204 0.83 ITGB1 (0.60) ITGB1ITGA4ITGB7ITGA5ITGAV
SCHEMBL7324679 0.82 ITGB1 (0.51) ITGB1ITGA4ITGB7ITGA5ITGAV
SCHEMBL7319192 0.82 ITGB1 (0.48) ITGB1ITGA4ITGB7ITGA5ITGAV
SCHEMBL7315537 0.81 ITGB1 (0.50) ITGB1ITGA4ITGB7ITGA5ITGAV
SCHEMBL7318950 0.81 ITGB1 (0.46) ITGB1ITGA4ITGB7ITGA5ITGAV

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1001972-A1 SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 Elan Pharmaceuticals, Inc. (US) 2000-05-24 EP claimed
WO-1999006431-A1 SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARMACEUTICALS, INC. (US) 1999-02-11 WO claimed